Controllable drug sustained-release hydrogel as well as preparation method and application thereof

By combining sodium alginate, sodium methacrylate and N,N-methylenebisacrylamide, a controlled drug sustained-release hydrogel was prepared, which solved the problem of unstable drug release rate and uncontrollable release cycle. The stability and 100% of the drug release amount are achieved to meet different drug treatment needs.

CN119033676APending Publication Date: 2024-11-29SUZHOU YIPU SCIENTIFIC INSTRUMENT CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411145800.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

Existing drug sustained-release hydrogels have problems with unstable drug release rate, incomplete release and uncontrollable release cycle, which is difficult to meet the needs of different drug treatment cycles.

Method used

Using raw materials such as sodium alginate, sodium methacrylate and N,N-methylenebisacrylamide, controllable drug sustained-release hydrogels are prepared through free radical polymerization, and the composition ratio and process of the hydrogel are regulated. Conditions to achieve stable drug release rate and controllable release cycle.

Benefits of technology

It achieves stability and 100% of the drug release rate and release amount, and can regulate the drug release cycle as needed, meet different drug treatment needs, and improves treatment efficiency and use efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119033676A_ABST
    Figure CN119033676A_ABST
Patent Text Reader

Abstract

The invention discloses controllable drug sustained-release hydrogel as well as a preparation method and application thereof, and belongs to the technical field of biomedical materials. Comprising the following steps: dissolving sodium alginate in deionized water to prepare a sodium alginate solution; stirring and mixing a hydrophobic drug and the sodium alginate solution to prepare a drug-loaded sodium alginate solution; stirring and mixing N, N-methylene bisacrylamide, sodium methacrylate and the sodium alginate solution loaded with the medicine to obtain a mixed solution; and uniformly mixing the mixed solution with an initiator, and polymerizing under the action of the initiator to obtain the controllable drug sustained-release hydrogel. The preparation process is simple, green and pollution-free, the hydrogel is used as a drug sustained-release material, the drug release rate is stable, the release efficiency is complete, the release period can be regulated and controlled, the sustained-release application requirements of different drugs can be completely met, and the hydrogel has wide application prospects in the fields of biomedical drug carriers and sustained-release materials.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biomedical materials, and specifically relates to a controllable drug sustained-release hydrogel and a preparation method and application thereof. Background Art

[0002] Hydrogels have achieved remarkable research results in the field of biomedical carriers. Most of the current drugs are hydrophobic drugs, which have poor solubility in water and seriously affect the body's uptake; the one-time administration method has a large dose and many times of medication, and there is a "peak and valley phenomenon" in drug concentration, which may lead to excessive local drug concentration and discomfort. However, through drug sustained-release hydrogel carriers, the number of administrations can be effectively reduced, the administration time can be extended, and the dosage can be controlled, which not only improves the treatment effect, but also enhances the patient's compliance with the drug.

[0003] Although drug-release hydrogels exhibit significant performance advantages, existing drug-release hydrogels have unstable drug release rates due to the limitations of their own network structures. The release rate is fast in the early stage and slow in the later stage, and the stability of drug release cannot be maintained, which greatly reduces the therapeutic effect. At the same time, due to the non-degradability of the hydrogel carrier, the maximum drug release value is also severely limited. Many hydrogels cannot completely release 100% of the loaded drugs, resulting in residues of drugs and gel carriers, greatly reducing the treatment efficiency. More importantly, the drug release cycle of most drug-release hydrogels is uncontrollable and cannot be artificially regulated, which affects the therapeutic effect.

[0004] Publication No. CN 109721742 B The patent application disclosed a soluble self-healing natural polymer hydrogel and its preparation method. The hydrogel includes natural polymer sodium alginate and methacrylic acid, wherein the mass ratio of natural polymer sodium alginate solution to methacrylic acid is 8-1:1. The hydrogel prepared in the patent is soluble and can be used as a drug carrier to completely release the loaded drug. However, the sodium alginate solution needs to be stabilized in a refrigerator at 3-10 ℃ for 3-10 h The polymerization temperature is 40-100 °C and the reaction time is 4-12 h , nitrogen protection is also required, and the preparation process conditions are harsh. For some hydrophobic flavonoid drugs, long-term heating at high temperatures will cause the drugs to oxidize and lose their activity. Moreover, the hydrogel cannot achieve the regulation of the hydrogel dissolution cycle and drug release cycle, and cannot meet the different needs of different drug treatment cycles.

[0005] Therefore, developing a controllable drug-release hydrogel that can maintain a stable release efficiency, achieve complete release of loaded drugs, and regulate the drug release cycle is of great significance for the controlled release of hydrophobic drugs in the field of biomedical materials. Summary of the invention

[0006] Purpose of the invention: In order to solve the problems of unstable drug release rate, incomplete release and uncontrollable release cycle in existing hydrophobic drug sustained-release hydrogel carriers, the present invention provides a controllable drug sustained-release hydrogel and its preparation method and application.

[0007] Technical solution: A method for preparing a controllable drug sustained-release hydrogel, comprising the following steps: Step 1, dissolving a certain amount of sodium alginate in deionized water, and stirring to obtain a sodium alginate solution; the mass ratio of the sodium alginate to the deionized water is (0.1-2.0):100; Step 2: Mixing and stirring the hydrophobic drug and the sodium alginate solution until the hydrophobic drug is completely dispersed in the sodium alginate solution to obtain a drug-sodium alginate mixed solution; the mass ratio of the hydrophobic drug to the sodium alginate solution is (1.0 ~ 4.0): 100; Step 3: Add the drug-sodium alginate mixed solution N , N -methylenebisacrylamide, stirring to obtain the drug -sodium alginate - N , N -methylenebisacrylamide mixed solution; the drug-sodium alginate mixed solution and N , N -The mass ratio of methylenebisacrylamide is 1.0: (0.1 ~ 0.01); Step 4: Drug-sodium alginate- N , N - Sodium methacrylate is added dropwise to the mixed solution of methylenebisacrylamide, and stirred after the addition is completed to obtain the drug - sodium alginate - N , N -Methylenebisacrylamide-sodium methacrylate mixed solution; the drug-sodium alginate- N , N -The mass ratio of methylenebisacrylamide mixed solution to sodium methacrylate is 1.0: (0.5 ~ 2.0); Step 5: Drug-sodium alginate- N , N -Methylenebisacrylamide-sodium methacrylate mixed solution is added with an initiator, and stirred after the addition is completed to obtain a multi-substance mixed solution; the drug-sodium alginate- N ,N -The mass ratio of methylenebisacrylamide-sodium methacrylate mixed solution to initiator is 100: (1.0 ~ 4.0); Step 6: Heat the multi-substance mixed solution to 45 ~ 55 °C, and react for 4.0 ~ 6.0 seconds. h , and then cooled to room temperature to obtain a drug sustained-release hydrogel.

[0008] Preferably, in the step 1, the temperature of the dissolution process of sodium alginate in deionized water is always maintained at 40° C. until the sodium alginate is completely dissolved.

[0009] Preferably, the stirring conditions in step 1 are: at 500-550 rpm Stir at a speed of 0.5~2 h .

[0010] Preferably, the molecular weight of sodium alginate in step 1 is 200 to 500 mPa · s .

[0011] Preferably, the stirring conditions in step 2 are: stirring speed 500~550 rpm , stirring time 4.0 ~6.0 h .

[0012] Preferably, in the step 2, the temperature of the dispersion process in which the hydrophobic drug is completely dispersed in the sodium alginate solution is always maintained at 40° C. until the hydrophobic drug is uniformly dispersed in the sodium alginate solution.

[0013] Preferably, the stirring condition in step 3 is to maintain the stirring speed at 500-550 rpm , stir 0.5 ~1 h .

[0014] Preferably, the dripping condition in step 4 is 1.0 h The addition was completed.

[0015] Preferably, the stirring conditions for stirring after the dropwise addition in step 4 are: maintaining a stirring speed of 500-550 rpm , keep stirring for 3.5~4.0 h .

[0016] Preferably, the stirring condition in step 5 is: maintaining the stirring speed at 500-550 rpm , stirring 2.0~2.5 h .

[0017] Preferably, in steps 3 to 5, the preparation temperature is always maintained at 25°C.

[0018] Preferably, the initiator in step 5 is one of potassium persulfate, ammonium persulfate, sodium persulfate or cerium persulfate.

[0019] Preferably, the hydrophobic drug is selected from one of ibuprofen, aspirin, azithromycin, indomethacin or ketorolac.

[0020] In another technical solution, a controllable drug sustained-release hydrogel is provided, which is prepared according to the preparation method of the controllable drug sustained-release hydrogel as described above.

[0021] In another technical solution, a use of the above-mentioned controllable drug sustained-release hydrogel in the preparation of a hydrophobic drug sustained-release carrier is provided.

[0022] The raw materials of the controlled drug sustained-release hydrogel in the present invention include: sodium alginate, sodium methacrylate, N , N -Methylene bisacrylamide and hydrophobic drugs. The molecular weight of sodium alginate is 200 ~ 500 mPa · s The raw materials used have the advantages of low toxicity, abundant raw materials, low price, easy biodegradability and high safety.

[0023] The hydrogel preparation process of the present invention is simple and easy to operate, the preparation conditions are loose, the preparation system is green and pollution-free, suitable for large-scale production, and has broad commercial prospects. The preparation method includes 6 steps: Step 1: Sodium alginate is dissolved and prepared at a dissolution temperature of 40°C and a dissolution time of only 0.5-2.0 h , a sodium alginate solution can be obtained without low temperature stability; Step 2: Preparation of drug-sodium alginate solution, using the viscosity of the sodium alginate solution, the hydrophobic drug can be evenly dispersed in the sodium alginate solution and maintained stable; Step 3: Drug-sodium alginate- N , N -Methylene bisacrylamide mixed solution preparation, the present invention uses N , N -Methylene bisacrylamide is an important component of the hydrogel, which can give the hydrogel excellent solubility and dissolution cycle controllability; Step 4: Drug-sodium alginate- N , N -methylenebisacrylamide-sodium methacrylate mixed solution preparation, the sodium methacrylate and the drug-sodium alginate- N , N-methylenebisacrylamide mixed solution ratio is (0.5 ~ 2.0): 1.0, sodium methacrylate in the present invention is an important component of the hydrogel, which can give the hydrogel excellent solubility and dissolution cycle controllability; Step 6: Preparation of hydrogel, the reaction temperature of this application is 45 ~ 55 ° C, and the reaction time is 4.0 ~ 6.0 h , the hydrogel can be obtained, the reaction temperature is lower, the time is shorter, and the preparation conditions are simpler.

[0024] The invention uses sodium alginate, hydrophobic drugs, sodium methacrylate and N , N -methylenebisacrylamide is used as the main raw material, and the target hydrogel is prepared by free radical polymerization in six steps. The preparation method of the present invention is simple and easy to operate, can be completed in one pot, the water system is pollution-free and residue-free, the synthetic method used is environmentally friendly, and is convenient for large-scale production and preparation.

[0025] The controllable drug sustained-release hydrogel prepared by the present invention has excellent mechanical properties, such as Figure 2 As shown in the figure, it can be seen that the hydrogels obtained in Examples 1 to 3 all exhibit excellent mechanical properties, among which the maximum strain of the hydrogel obtained in Example 1 is 65.26%, corresponding to a maximum stress value of 39.81. kPa The maximum strain of the hydrogel obtained in Example 2 was 74.16%, corresponding to a maximum stress value of 48.32. kPa The maximum strain of the hydrogel obtained in Example 3 was 126.47%, corresponding to a maximum stress value of 52.77 kPa .

[0026] The controllable drug sustained-release hydrogel prepared in the present application not only has excellent dissolution performance and can be rapidly dissolved without external force, but also can prepare hydrogels with different dissolution cycles by regulating the proportion of components in the hydrogel, such as Figure 3 As shown in the figure, it can be seen that the dissolution time of the hydrogel obtained in Example 1 is 4.47 h The dissolution time of the hydrogel obtained in Example 2 was 29.76 h The dissolution time of the hydrogel obtained in Example 3 was 61.94 h .

[0027] The controllable drug sustained-release hydrogel prepared in this application has controllable drug release cycle. Based on the controllable dissolution of the hydrogel prepared in this application, it is applied to drug carriers to achieve complete release of the loaded hydrophobic drug, with a release amount of 100%. After release, the hydrogel is completely dissolved, and no drug and hydrogel remain. In addition, the drug release cycle can also be regulated, such as Figure 4As shown in the figure, it can be seen that the hydrogels obtained in Examples 1 to 3 exhibit different drug release cycles, among which the ibuprofen sustained release cycle of the hydrogel obtained in Example 1 is 5 h Example 2 The resulting hydrogel ibuprofen release period is 24 h The release period of ibuprofen in the hydrogel obtained in Example 3 is 72 h .

[0028] A controllable drug sustained-release hydrogel prepared by the present invention has a three-dimensional network structure, can effectively load drug molecules, and through the porous structure, can achieve drug molecules in the hydrogel migration, complete the slow release of the loaded drug in the hydrogel. At the same time, the excellent solubility of the hydrogel can ensure that the loaded drug release rate is stable, the drug release is complete, and there is no residue. In addition, the controllability of the hydrogel dissolution cycle can ensure that the drug release cycle is regulated to meet the needs of the differences in the treatment cycles of different drugs.

[0029] The hydrogel prepared by the present invention has remarkable advantages such as excellent hydrophobic drug loading capacity, stable sustained release capacity of hydrophobic drugs, complete release and adjustable release cycle. Using it as a drug carrier and applying it to biomedical loading can effectively solve the problems of poor stability, incomplete release and uncontrollable release cycle of hydrophobic drugs existing in traditional hydrogel drug carriers, significantly improve the use efficiency and reduce the use cost. The hydrogel obtained by the present invention integrates complete drug release and degradable drug carrier, and has broad application prospects in the field of biomedical carriers.

[0030] Beneficial effects: (1) The present invention utilizes the high viscosity of biomass polymer sodium alginate solution to evenly disperse hydrophobic drugs in the sodium alginate solution, thereby solving the problem of dissolution of hydrophobic drugs.

[0031] (2) The present invention utilizes biomass polymer sodium alginate, sodium methacrylate and N , N -Methylenebisacrylamide forms a three-dimensional network structure, which can effectively load hydrophobic drug molecules and release hydrophobic drugs through the hydrogel network structure.

[0032] (3) The present invention combines the carboxyl groups in the molecular structure of biomass polymer sodium alginate with the carboxyl groups in the molecular structure of sodium methacrylate and N , N -The electrostatic interaction and hydrogen bonding between the amine groups in the molecular structure of methylenebisacrylamide give the hydrogel excellent mechanical properties and solubility.

[0033] (4) The present invention utilizes the excellent solubility properties of the hydrogel itself and uses it as a hydrophobic drug carrier. The loaded hydrophobic drug is slowly released as the hydrogel dissolves, and the drug release rate is stable.

[0034] (5) The present invention utilizes the excellent solubility properties of the hydrogel itself and uses it as a hydrophobic drug carrier. As the hydrophobic drug is released, the hydrogel drug carrier will gradually dissolve. Eventually, the hydrogel is completely dissolved, the loaded drug is completely released, and no drug or hydrogel carrier remains.

[0035] (6) The present invention can effectively regulate the dissolution cycle of the hydrogel by changing the feed ratio of the hydrogel raw materials and improving the cross-linking density of the hydrogel network structure, thereby achieving regulation of the sustained-release cycle of the hydrophobic drug, meeting the requirements of the release cycle of drugs for treating different diseases, and can customize the hydrogel carrier on demand. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1 is the infrared spectrum of the hydrogel obtained in Example 1; Figure 2 is a graph showing the mechanical properties of the hydrogels obtained in Examples 1 to 3; Figure 3 is the dissolution properties of the hydrogels obtained in Examples 1 to 3; Figure 4 is the drug release performance of the hydrogels obtained in Examples 1 to 3; Figure 5 This is the drug release performance of the hydrogels obtained in Comparative Examples 5 to 6. DETAILED DESCRIPTION

[0037] Example 1 A method for preparing a controllable drug sustained-release hydrogel comprises the following steps: Step 1: 2.0 g Sodium alginate was dissolved in 100 g In deionized water, at 500 rpm Stir at a speed of 2.0 h , and the temperature is maintained at 40°C until the sodium alginate is completely dissolved to obtain a sodium alginate solution.

[0038] Step 2: Weigh 10 g Prepare the sodium alginate solution in step 1, add 0.1 g The ibuprofen was dispersed in the sodium alginate solution and stirred at a speed of 500 rpm , stirring time is 4.0 h , the temperature is maintained at 40°C, until the ibuprofen is completely dispersed in the sodium alginate solution to obtain an ibuprofen-sodium alginate aqueous solution.

[0039] Step 3, weigh 1.0 g Slowly add 0.1% sodium alginate into the ibuprofen-sodium alginate solution prepared in step 2. g of N , N -Methylene bisacrylamide, maintain stirring speed 500 rpm , stirring time 0.5 h , stirring temperature 25 ℃, stirring time 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution.

[0040] Step 4: Add the ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution was slowly added with 0.55 g Sodium methacrylate, 1.0 h After the addition is complete, maintain stirring speed at 500 rpm After the addition is complete, continue stirring for 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide-sodium methacrylate mixed solution.

[0041] Step 5: Slowly add 0.0165 g The initiator ammonium persulfate was maintained at a stirring speed of 500 rpm , stirring 2.0 h .

[0042] Step 6: Heat the solution obtained in step 5 to 45°C for 4.0 h , and then cooled to room temperature to obtain the controllable drug sustained-release hydrogel.

[0043] Figure 1 This is the infrared spectrum of the hydrogel in Example 1. The characteristic peaks of the functional groups in the figure confirm that the hydrogel is successfully synthesized.

[0044] Example 2 A method for preparing a controllable drug sustained-release hydrogel comprises the following steps: Step 1: 0.1 g Sodium alginate was dissolved in 100 g In deionized water, at 500 rpm Stir at a speed of 0.5 h , and the temperature is maintained at 40°C until the sodium alginate is completely dissolved to obtain a sodium alginate solution.

[0045] Step 2: Weigh 10 g Prepare the sodium alginate solution in step 1, add 0.1 g The ibuprofen was dispersed in the sodium alginate solution and stirred at a speed of 500 rpm , stirring time is 4.0 h , the temperature is maintained at 40°C, until the ibuprofen is completely dispersed in the sodium alginate solution to obtain an ibuprofen-sodium alginate aqueous solution.

[0046] Step 3, weigh 1.0 g Slowly add 0.01% ibuprofen-sodium alginate solution prepared in step 2 g of N , N -Methylene bisacrylamide, maintain stirring speed 500 rpm , stirring time 0.5 h , stirring temperature 25 ℃, stirring time 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution.

[0047] Step 4: Add the ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution was slowly added dropwise 2.02 g Sodium methacrylate, 1.0 h After the addition is complete, maintain stirring speed at 500 rpm After the addition is complete, continue stirring for 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide-sodium methacrylate mixed solution.

[0048] Step 5: Slowly add 0.121 g The initiator ammonium persulfate was maintained at a stirring speed of 500 rpm , stirring 2.0 h .

[0049] Step 6: Heat the solution obtained in step 5 to 55°C for 6.0 min. h , and then cooled to room temperature to obtain the controllable drug sustained-release hydrogel.

[0050] Example 3 A method for preparing a controllable drug sustained-release hydrogel comprises the following steps: Step 1: 1.5 g Sodium alginate was dissolved in 100 gIn deionized water, at 500 rpm Stir at a speed of 1.0 h , and the temperature is maintained at 40°C until the sodium alginate is completely dissolved to obtain a sodium alginate solution.

[0051] Step 2: Weigh 10 g Prepare the sodium alginate solution in step 1, add 0.1 g The ibuprofen was dispersed in the sodium alginate solution and stirred at a speed of 500 rpm , stirring time is 4.0 h , the temperature is maintained at 40°C, until the ibuprofen is completely dispersed in the sodium alginate solution to obtain an ibuprofen-sodium alginate aqueous solution.

[0052] Step 3, weigh 1.0 g Slowly add 0.05% sodium alginate into the ibuprofen-sodium alginate solution prepared in step 2. g of N , N -Methylene bisacrylamide, maintain stirring speed 500 rpm , stirring time 0.5 h , stirring temperature 25 ℃, stirring time 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution.

[0053] Step 4: Add the ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution was slowly added with 1.05 g Sodium methacrylate, 1.0 h After the addition is complete, maintain stirring speed at 500 rpm After the addition is complete, continue stirring for 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide-sodium methacrylate mixed solution.

[0054] Step 5: Slowly add 0.042 g The initiator ammonium persulfate was maintained at a stirring speed of 500 rpm , stirring 2.0 h .

[0055] Step 6: Heat the solution obtained in step 5 to 50°C for 5.0 h , and then cooled to room temperature to obtain the controllable drug sustained-release hydrogel.

[0056] Example 4 A method for preparing a controllable drug sustained-release hydrogel comprises the following steps: Step 1: 2.0 g Sodium alginate was dissolved in 100 g In deionized water, at 500 rpm Stir at a speed of 2.0 h , and the temperature is maintained at 40°C until the sodium alginate is completely dissolved to obtain a sodium alginate solution.

[0057] Step 2: Weigh 10 g Prepare the sodium alginate solution in step 1, add 0.4 g The ibuprofen was dispersed in the sodium alginate solution and stirred at a speed of 500 rpm , stirring time is 6.0 h , the temperature is maintained at 40°C, until the ibuprofen is completely dispersed in the sodium alginate solution to obtain an ibuprofen-sodium alginate aqueous solution.

[0058] Step 3, weigh 1.0 g Slowly add 0.1% sodium alginate into the ibuprofen-sodium alginate solution prepared in step 2. g of N , N -Methylene bisacrylamide, maintain stirring speed 500 rpm , stirring time 0.5 h , stirring temperature 25 ℃, stirring time 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution.

[0059] Step 4: Add the ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution was slowly added with 0.55 g Sodium methacrylate, 1.0 h After the addition is complete, maintain stirring speed at 500 rpm After the addition is complete, continue stirring for 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide-sodium methacrylate mixed solution.

[0060] Step 5: Slowly add 0.0165 g The initiator ammonium persulfate was maintained at a stirring speed of 500 rpm , stirring 2.0 h .

[0061] Step 6: Heat the solution obtained in step 5 to 45°C for 4.0 h , and then cooled to room temperature to obtain the controllable drug sustained-release hydrogel.

[0062] Example 5 A method for preparing a controllable drug sustained-release hydrogel comprises the following steps: Step 1: 2.0 g Sodium alginate was dissolved in 100 g In deionized water, at 500 rpm Stir at a speed of 2.0 h , and the temperature is maintained at 40°C until the sodium alginate is completely dissolved to obtain a sodium alginate solution.

[0063] Step 2: Weigh 10 g Prepare the sodium alginate solution in step 1, add 0.4 g Aspirin was dispersed in the sodium alginate solution and stirred continuously at a speed of 500 rpm , stirring time is 6.0 h , the temperature is maintained at 40°C, until the ibuprofen is completely dispersed in the sodium alginate solution to obtain an aspirin-sodium alginate aqueous solution.

[0064] Step 3, weigh 1.0 g Slowly add 0.1% sodium alginate to the aspirin-sodium alginate solution prepared in step 2. g of N , N -Methylene bisacrylamide, maintain stirring speed 500 rpm , stirring time 0.5 h , stirring temperature 25 ℃, stirring time 4.0 h , get aspirin-sodium alginate- N , N -Methylenebisacrylamide mixed solution.

[0065] Step 4: Add the aspirin-sodium alginate- N , N -Methylenebisacrylamide mixed solution was slowly added with 0.55 g Sodium methacrylate, 1.0 h After the addition is complete, maintain stirring speed at 500 rpm After the addition is complete, continue stirring for 4.0 h , get aspirin-sodium alginate- N , N -Methylenebisacrylamide-sodium methacrylate mixed solution.

[0066] Step 5: Slowly add 0.0165 g The initiator ammonium persulfate was maintained at a stirring speed of 500 rpm , stirring 2.0 h .

[0067] Step 6: Heat the solution obtained in step 5 to 45°C and continue stirring for 4.0 h , and then cooled to room temperature to obtain the controllable drug sustained-release hydrogel.

[0068] Example 6 The mechanical properties of the controllable drug sustained-release hydrogel obtained in Examples 1 to 3 of the present invention were measured.

[0069] The mechanical properties of the hydrogels obtained in Examples 1 to 3 were measured by a mechanical tensile tester, and the tensile rate was 5 mm / min , stress-strain curves of hydrogel mechanical properties, such as Figure 2 As shown in the figure, the hydrogels obtained in Examples 1 to 3 all exhibited excellent mechanical properties, among which the maximum strain of the hydrogel obtained in Example 1 was 65.26%, corresponding to a maximum stress value of 39.81 kPa The maximum strain of the hydrogel obtained in Example 2 was 74.16%, corresponding to a maximum stress value of 48.32. kPa The maximum strain of the hydrogel obtained in Example 3 was 126.47%, corresponding to a maximum stress value of 52.77 kPa .

[0070] Example 7 The solubility properties of the controllable drug sustained-release hydrogel obtained in specific examples 1 to 3 of the present invention were measured.

[0071] Weigh 1.0 g 5.0% ethanol was added to the hydrogels obtained in Examples 1 to 3. g Deionized water, then record the hydrogel mass and determine the hydrogel dissolution properties. Figure 3 As shown in the figure, in the initial stage, the mass of the hydrogel gradually increases with time. This is because the hydrogel itself has a certain swelling property. When the hydrogel is placed in deionized water, the hydrogel quickly absorbs deionized water, and then the mass of the hydrogel continues to increase. When the hydrogel is saturated with adsorption, the mass reaches the maximum value. When it continues to be immersed in deionized water, the hydrogel gradually begins to dissolve, its own mass continues to decrease, and finally completely dissolves. The mass of the hydrogel is 0 and remains unchanged.

[0072] This process proves that the obtained controlled drug sustained-release hydrogel has excellent dissolution performance. And with the different components in the hydrogel, the hydrogel dissolution period is also different. By adjusting the proportion of the components in the hydrogel, hydrogels with different dissolution periods can be prepared. It can be seen from the figure that the dissolution time of the hydrogel obtained in Example 1 is 4.47 h The dissolution time of the hydrogel obtained in Example 2 was 29.76 h The dissolution time of the hydrogel obtained in Example 3 was 61.94 h .

[0073] Example 8 In vitro drug release curves of a controllable drug sustained-release hydrogel obtained in specific examples 1 to 3 of the present invention.

[0074] Weigh 1.0 g 5.0% ethanol was added to the hydrogels obtained in Examples 1 to 3. g , pH The phosphate buffer solution was maintained at 36.5°C and the ibuprofen content in the deionized water was measured at different time intervals until the ibuprofen content remained unchanged. The solution was taken out and supplemented with 1 mL The solution was taken out, and the ibuprofen content in the taken out solution was quantitatively determined by ultraviolet spectrophotometer, the cumulative release data of ibuprofen was calculated, the relationship between the change of ibuprofen content and release time was recorded, and the sustained release performance of the hydrogel drug was determined.

[0075] like Figure 4 As shown, the hydrogels obtained in Examples 1 to 3 all exhibited excellent ibuprofen sustained-release performance, and the ibuprofen release amount and release time showed a good linear relationship. The release rate remained stable throughout, and there was no problem of fast release rate in the early stage and slow release in the later stage. At the same time, based on the excellent solubility performance exhibited by the hydrogels obtained in Examples 1 to 3, the hydrogels obtained in Examples 1 to 3 were able to achieve complete release of the loaded ibuprofen drug, with a release amount of 100%, and after release, the hydrogel was completely dissolved, with no drug and hydrogel residue. In addition, the hydrogels obtained in Examples 1 to 3 exhibited different ibuprofen release cycles, of which the ibuprofen sustained-release cycle of the hydrogel obtained in Example 1 was 5 h Example 2 The resulting hydrogel ibuprofen release period is 24 h The release period of ibuprofen in the hydrogel obtained in Example 3 is 72 h .

[0076] Comparative Example 1 Step 1: 2.0 g Sodium alginate was dissolved in 50 g In deionized water, at 500 rpm Stir at a speed of 2.0h , the temperature is kept at 20 ℃, sodium alginate cannot be completely dissolved and sodium alginate solution cannot be obtained.

[0077] Comparative Example 2 Step 1: 2.0 g Sodium alginate was dissolved in 100 g In deionized water, at 500 rpm Stir at a speed of 2.0 h , and the temperature is maintained at 40°C until the sodium alginate is completely dissolved to obtain a sodium alginate solution.

[0078] Step 2: Weigh 10 g Prepare the sodium alginate solution in step 1 and add 1.0 g The ibuprofen was dispersed in the sodium alginate solution and stirred continuously at a stirring speed of 500 rpm , stirring time is 4.0 h , the temperature was kept at 40 °C, and ibuprofen could not be completely and evenly dispersed in the sodium alginate solution.

[0079] Comparative Example 3 Step 1: 2.0 g Sodium alginate was dissolved in 100 g In deionized water, at 500 rpm Stir at a speed of 2.0 h , and the temperature is maintained at 40°C until the sodium alginate is completely dissolved to obtain a sodium alginate solution.

[0080] Step 2: Weigh 10 g Prepare the sodium alginate solution in step 1, add 0.1 g The ibuprofen was dispersed in the sodium alginate solution and stirred continuously at a stirring speed of 500 rpm , stirring time is 4.0 h , the temperature is maintained at 40°C, until the ibuprofen is completely dispersed in the sodium alginate solution to obtain an ibuprofen-sodium alginate aqueous solution.

[0081] Step 3, weigh 1.0 g Slowly add 0.55% of the ibuprofen-sodium alginate solution prepared in step 2 g The sodium alginate solution will quickly aggregate to form a gel mass and cannot form a solution.

[0082] Comparative Example 4 Step 1: 2.0 g Sodium alginate was dissolved in 100 g In deionized water, at 500 rpm Stir at a speed of 2.0 h, and the temperature is maintained at 40°C until the sodium alginate is completely dissolved to obtain a sodium alginate solution.

[0083] Step 2: Weigh 10 g Prepare the sodium alginate solution in step 1, add 0.1 g The ibuprofen was dispersed in the sodium alginate solution and stirred continuously at a stirring speed of 500 rpm , stirring time is 4.0 h , the temperature is maintained at 40°C, until the ibuprofen is completely dispersed in the sodium alginate solution to obtain an ibuprofen-sodium alginate aqueous solution.

[0084] Step 3, weigh 1.0 g Slowly add 1.0 g of N , N -Methylene bisacrylamide, maintain stirring speed 500 rpm , stirring time 0.5 h , stirring temperature 25 ℃, stirring time 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution.

[0085] Step 4: Add the ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution was slowly added with 0.55 g Acrylic acid, 1.0 h After the addition is complete, maintain stirring speed at 500 rpm After the addition is complete, continue stirring for 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide-sodium acrylate mixed solution.

[0086] Step 5: Slowly add 0.0165 g The initiator ammonium persulfate was maintained at a stirring speed of 500 rpm , stirring 2.0 h .

[0087] Step 6: Heat the solution obtained in step 5 to 30 °C and continue stirring for 4.0 h , and then cooled to room temperature, no hydrogel could be obtained.

[0088] Comparative Example 5 Step 1: 2.0 g Sodium alginate was dissolved in 100g In deionized water, at 500 rpm Stir at a speed of 2.0 h , and the temperature is maintained at 40°C until the sodium alginate is completely dissolved to obtain a sodium alginate solution.

[0089] Step 2: Weigh 10 g Prepare the sodium alginate solution in step 1, add 0.1 g The ibuprofen was dispersed in the sodium alginate solution and stirred continuously at a stirring speed of 500 rpm , stirring time is 4.0 h , the temperature is maintained at 40°C, until the ibuprofen is completely dispersed in the sodium alginate solution to obtain an ibuprofen-sodium alginate aqueous solution.

[0090] Step 3, weigh 1.0 g Slowly add 0.1% sodium alginate into the ibuprofen-sodium alginate solution prepared in step 2. g of N , N -Methylene bisacrylamide, maintain stirring speed 500 rpm , stirring time 0.5 h , stirring temperature 25 ℃, stirring time 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution.

[0091] Step 4: Add the ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution was slowly added with 0.55 g Acrylic acid, 1.0 h After the addition is complete, maintain stirring speed at 500 rpm After the addition is complete, continue stirring for 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide-sodium acrylate mixed solution.

[0092] Step 5: Slowly add 0.0165 g The initiator ammonium persulfate was maintained at a stirring speed of 500 rpm , stirring 2.0 h .

[0093] Step 6: Heat the solution obtained in step 5 to 50 °C and continue stirring for 4.0 h, and then cooled to room temperature to obtain a hydrogel. However, the gel did not have soluble properties, the drug release was incomplete, the maximum release rate was only 31%, and after the release was constant, the hydrogel did not dissolve.

[0094] Comparative Example 6 Step 1: 2.0 g Sodium alginate was dissolved in 100 g In deionized water, at 500 rpm Stir at a speed of 2.0 h , and the temperature is maintained at 40°C until the sodium alginate is completely dissolved to obtain a sodium alginate solution.

[0095] Step 2: Weigh 10 g Prepare the sodium alginate solution in step 1, add 0.1 g The ibuprofen was dispersed in the sodium alginate solution and stirred continuously at a stirring speed of 500 rpm , stirring time is 4.0 h , the temperature is maintained at 40°C, until the ibuprofen is completely dispersed in the sodium alginate solution to obtain an ibuprofen-sodium alginate aqueous solution.

[0096] Step 3, weigh 1.0 g Slowly add 0.1% sodium alginate into the ibuprofen-sodium alginate solution prepared in step 2. g of N , N -Methylene bisacrylamide, maintain stirring speed 500 rpm , stirring time 0.5 h , stirring temperature 25 ℃, stirring time 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution.

[0097] Step 4: Add the ibuprofen-sodium alginate- N , N -Methylenebisacrylamide mixed solution was slowly added with 0.55 g Methacrylic acid, 1.0 h After the addition is complete, maintain stirring speed at 500 rpm After the addition is complete, continue stirring for 4.0 h , get ibuprofen-sodium alginate- N , N -Methylenebisacrylamide-sodium methacrylate mixed solution.

[0098] Step 5: Slowly add 0.0165 gThe initiator ammonium persulfate was maintained at a stirring speed of 500 rpm , stirring 2.0 h .

[0099] Step 6: Heat the solution obtained in step 5 to 50 °C and continue stirring for 4.0 h , and then cooled to room temperature to obtain a hydrogel. However, the gel does not have soluble properties, the drug release is incomplete, the maximum release rate is only 64%, and after the release is constant, the hydrogel does not dissolve.

[0100] Comparative Example 7 Step 1: 2.0 g Sodium alginate was dissolved in 100 g In deionized water, at 500 rpm Stir at a speed of 2.0 h , and the temperature is maintained at 40°C until the sodium alginate is completely dissolved to obtain a sodium alginate solution.

[0101] Step 2: Weigh 10 g Prepare the sodium alginate solution in step 1, add 0.1 g The ibuprofen was dispersed in the sodium alginate solution and stirred continuously at a stirring speed of 500 rpm , stirring time is 4.0 h , the temperature is maintained at 40°C, until the ibuprofen is completely dispersed in the sodium alginate solution to obtain an ibuprofen-sodium alginate aqueous solution.

[0102] Step 3, weigh 1.0 g Slowly add 2.0% sodium alginate to the ibuprofen-sodium alginate solution prepared in step 2. g Methacrylic acid, 1.0 h After the addition is complete, maintain stirring speed at 500 rpm After the addition is complete, continue stirring for 4.0 h , the ibuprofen-sodium alginate mixed solution will show flocculation phenomenon.

Claims

1. A method for preparing a controllable drug sustained-release hydrogel, characterized in that: The following steps are involved: Step 1, dissolving a certain amount of sodium alginate in deionized water, and stirring to obtain a sodium alginate solution; the mass ratio of the sodium alginate to the deionized water is (0.1-2.0):100; Step 2, mixing and stirring the hydrophobic drug and the sodium alginate solution, until the hydrophobic drug is completely dispersed in the sodium alginate solution, to obtain a drug-sodium alginate mixed solution; the mass ratio of the hydrophobic drug to the sodium alginate solution is (1.0 ~ 4.0): 100; Step 3: Add the drug-sodium alginate mixed solution N , N -methylenebisacrylamide, stirring to obtain the drug -sodium alginate - N , N -Methylenebisacrylamide mixed solution; The mixed solution of the drug and sodium alginate N , N -The mass ratio of methylenebisacrylamide is 1.0: (0.1 ~ 0.01); Step 4: Drug-sodium alginate- N , N - Sodium methacrylate is added dropwise to the mixed solution of methylenebisacrylamide, and stirred after the addition is completed to obtain the drug - sodium alginate - N , N -Methylenebisacrylamide-sodium methacrylate mixed solution; the drug-sodium alginate- N , N -The mass ratio of methylenebisacrylamide mixed solution to sodium methacrylate is 1.0: (0.5 ~ 2.0); Step 5: Drug-sodium alginate- N , N -Methylenebisacrylamide-sodium methacrylate mixed solution is added with an initiator, and stirred after the addition is completed to obtain a multi-substance mixed solution; the drug-sodium alginate- N , N -The mass ratio of methylenebisacrylamide-sodium methacrylate mixed solution to initiator is 100: (1.0 ~ 4.0); Step 6: Heat the multi-substance mixed solution to 45 ~ 55 °C, and react for 4.0 ~ 6.0 seconds. h , and then cooled to room temperature to obtain a drug sustained-release hydrogel.

2. The method for preparing a controllable drug sustained-release hydrogel according to claim 1, characterized in that: In the step 1, the temperature of the sodium alginate dissolving in deionized water is always maintained at 38-40° C. until the sodium alginate is completely dissolved.

3. The method for preparing a controllable drug sustained-release hydrogel according to claim 1, characterized in that: In the step 2, the temperature of the dispersion process in which the hydrophobic drug is completely dispersed in the sodium alginate solution is always maintained at 38-40° C. until the hydrophobic drug is uniformly dispersed in the sodium alginate solution.

4. The method for preparing a controllable drug sustained-release hydrogel according to claim 1, characterized in that: The preparation temperature in steps 3 to 5 is always maintained at 25-26°C.

5. The method for preparing a controllable drug sustained-release hydrogel according to claim 1, characterized in that: The molecular weight of the sodium alginate in step 1 is 200 to 500 mPa · s .

6. The method for preparing a controllable drug sustained-release hydrogel according to claim 1, characterized in that: The initiator in step 5 is one of potassium persulfate, ammonium persulfate, sodium persulfate or cerium persulfate.

7. A controllable drug sustained-release hydrogel, characterized in that: The controlled drug sustained-release hydrogel is prepared according to the method for preparing the controlled drug sustained-release hydrogel according to any one of claims 1 to 6.

8. Use of the controllable drug sustained-release hydrogel according to claim 7 in preparing a hydrophobic drug sustained-release carrier.

Citation Information

Cited By

  • Photocatalytic response type pressure-driven self-releasing drug composite hydrogel microspheres, and preparation method and application thereof

    CN122768195A